// App-Quantinova.ai

: The Effect of Tiotropium/Olodaterol Versus Tiotropium on Breathlessness During the 3-Minute Constant Speed Shuttle Walking Test in Patients with Chronic Obstructive Pulmonary Disease

Researchers

Presenter

  • F. Maltais

Principal Investigators

  • J. Aumann

  • A. Kirsten

  • E. Nadreau

  • H. Macesic

  • X. Jin

  • A. L. Hamilton

  • D. E. O'Donnell

Medical Centers

  • Centre de Pneumologie, Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Quebec, QC, Canada,

  • Longartsenpraktijk, Hasselt, Belgium,

  • Pulmonary Research Institute at LungenClinic Grosshansdorf, Grosshansdorf, Germany,

  • Boehringer Ingelheim (Canada) Ltd./Ltee, Burlington, ON, Canada

  • Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, United States.

  • Queens Univ, Kingston General Hosp, Kingston, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tiotropium/olodaterol

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved